Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. [PDF]
ABSTRACT. Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four monthly cycles during malaria transmission season was recommended by the WHO in 2012 and has been implemented in 13 countries in the Sahel, reaching more than 30 million children annually.
Thwing J +3 more
europepmc +3 more sources
Effect of Seasonal Malaria Chemoprevention on Immune Markers of Exhaustion and Regulation [PDF]
Abstract Background Seasonal malaria chemoprevention (SMC) is a novel strategy to reduce malaria infections in children. Infection with Plasmodium falciparum results in immune dysfunction characterized by elevated expression of markers associated with exhaustion, such as PD1 and LAG3, and regulatory ...
Oumar, Attaher +18 more
openaire +2 more sources
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. [PDF]
BACKGROUND: Malaria and anaemia are the leading causes of morbidity and mortality in children in sub-Saharan Africa. We have investigated the effect of intermittent preventive treatment with sulphadoxine-pyrimethamine or artesunate plus amodiaquine on ...
Kweku Margaret +20 more
core +1 more source
Background The only licensed malaria vaccine, RTS,S/AS01, has been developed for morbidity-control in young children. The potential impact on transmission of deploying such anti-infective vaccines to wider age ranges, possibly with co-administration of ...
Flavia Camponovo +3 more
doaj +1 more source
Seasonal Malaria Chemoprevention Coverage in Guinea in 2019 [PDF]
SMC involves the administration of a treatment course of sulfadoxine-pyrimethamine plus amodiaquine once a month to children aged 3–59 months during the high risk period each year to prevent malaria. SMC over 4 months of the year was introduced in Guinea in 2015 in 6 prefectures, scaling up to 13 prefectures by 2018. The present survey was conducted at
Loua, Kovana Marcel, Milligan, Paul
openaire +1 more source
Temporal Variations in Malaria Risk in Africa [PDF]
In sub-Saharan Africa, malaria is a major cause of morbidity and mortality especially among children less than five years of age and pregnant women. Malaria situations are very diverse because of many factors involved in malaria transmission and the ...
Mabaso, Musawenkosi L. H.
core +1 more source
Introduction Seasonal malaria chemoprevention (SMC), with sulphadoxine–pyrimethamine plus amodiaquine (SP+AQ) is effective but does not provide complete protection against clinical malaria.
Ismaila Thera +18 more
openaire +3 more sources
Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review. [PDF]
Abstract Background Children under five are the vulnerable population most at risk of being infected with Plasmodium parasites, especially in the Sahel region. Seasonal malaria chemoprevention (SMC) recommended by World Health Organization (WHO), has proven to be a highly effective intervention to prevent malaria.
Xu M +10 more
europepmc +4 more sources
Longitudinal analysis of the capacities of community health workers mobilized for seasonal malaria chemoprevention in Burkina Faso [PDF]
Results of the study confirm the capacity of community health workers, or “community-based distributors” (CBDs), under routine programme implementation of seasonal malaria chemoprevention (SMC).
Kombate, Gountante +5 more
core +1 more source
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial. [PDF]
BACKGROUND: Intermittent preventive treatment of malaria in children (IPTc) is a promising new approach to the control of malaria in areas of seasonal malaria transmission but it is not known if IPTc adds to the protection provided by an insecticide ...
Issa N Ouédraogo +61 more
core +1 more source

